Sterling Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Sterling Capital Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.84M	Buy	12,738 +703	+6%	+$538K	0.19%	99
2025 Q4	$9.29M	Buy	12,035 +8,441	+235%	+$5.73M	0.15%	113
2025 Q3	$2.02M	Sell	3,594 -693	-16%	-$392K	0.03%	392
2025 Q2	$2.25M	Buy	4,287 +615	+17%	+$343K	0.03%	353
2025 Q1	$2.33M	Buy	3,672 +747	+26%	+$514K	0.04%	320
2024 Q4	$2.08M	Sell	2,925 -297	-9%	-$249K	0.03%	396
2024 Q3	$3.39M	Buy	+3,222	New	+$3.59M	0.04%	283
2019 Q3	$377K	Buy	1,358 +42	+3%	+$12.4K	﹤0.01%	783
2019 Q2	$412K	Sell	1,316 -15,901	-92%	-$5.29M	﹤0.01%	775
2019 Q1	$7.07M	Buy	17,217 +15,594	+961%	+$6.42M	0.07%	208
2018 Q4	$606K	Sell	1,623 -9	-0.6%	-$3.29K	0.01%	713
2018 Q3	$659K	Sell	1,632 -10	-0.6%	-$3.81K	0.01%	751
2018 Q2	$566K	Buy	1,642 +359	+28%	+$112K	0.01%	741
2018 Q1	$442K	Sell	1,283 -6,511	-84%	-$2.26M	﹤0.01%	770
2017 Q4	$2.93M	Sell	7,794 -5,939	-43%	-$2.41M	0.03%	338
2017 Q3	$6.14M	Sell	13,733 -3,671	-21%	-$1.75M	0.06%	223
2017 Q2	$8.55M	Sell	17,404 -133	-0.8%	-$58.2K	0.08%	194
2017 Q1	$6.8M	Buy	17,537 +105	+0.6%	+$38.9K	0.06%	219
2016 Q4	$6.4M	Sell	17,432 -644	-4%	-$245K	0.06%	218
2016 Q3	$7.27M	Buy	18,076 +848	+5%	+$340K	0.07%	203
2016 Q2	$6.02M	Hold	17,228	–	–	0.06%	226
2016 Q1	$6.21M	Buy	17,228 +449	+3%	+$185K	0.06%	224
2015 Q4	$9.11M	Sell	16,779 -1,127	-6%	-$611K	0.08%	181
2015 Q3	$8.33M	Hold	17,906	–	–	0.07%	181
2015 Q2	$9.13M	Sell	17,906 -650	-4%	-$317K	0.08%	128
2015 Q1	$8.38M	Sell	18,556 -1,360	-7%	-$576K	0.07%	128
2014 Q4	$8.17M	Sell	19,916 -5,246	-21%	-$2.06M	0.07%	128
2014 Q3	$9.07M	Sell	25,162 -4,730	-16%	-$1.59M	0.11%	121
2014 Q2	$8.44M	Sell	29,892 -2,839	-9%	-$841K	0.07%	129
2014 Q1	$9.83M	Sell	32,731 -4,469	-12%	-$1.38M	0.08%	131
2013 Q4	$10.2M	Buy	+37,200	New	+$10.7M	0.09%	131